LAUNCHING OF THE HEcoPerMed PROJECT
We proudly announce the launching of the HEcoPerMed (Healthcare- and pharma-economics in support of the International Consortium for Personalised Medicine – ICPerMed) project in which Syreon Research Institute is the leader of the 2nd work package.
The €2 million project – funded by European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 824997 – will run from 2019-2021 under the leading of Austrian Institute of Technology (AIT). The project responds to the demand for economic models that evaluate treatments made possible through innovations in personalised medicine. HEcoPerMed also seeks to identify funding and reimbursement mechanisms that provide financial incentives for the rapid development and uptake of such innovations. HEcoPerMed goes beyond current assessment and payment models in order to serve the need of personalised medicine for more comprehensive cost-effectiveness estimates – incorporating patient and societal perspectives – and for sustainable affordability of cutting-edge health innovations. The kick-off meeting was held in Brussels on the 28th and 29th of January, 2019.
More information: http://hecopermed.eu/
